PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Journal of Cardiovascular Pharmacology3 citations

Cannabidiol Protects the Heart from Ischemia-Reperfusion Injury Through SIRT-1/PGC-1α Activation and NF-κB Modulation: Experimental Insights

View Full Paper
FAFatih AksoyMSMehtap SavranDUDinçer Uysal

Key Points

  • This study aims to evaluate the cardioprotective effects of cannabidiol (CBD) in a rat model of myocardial ischemia-reperfusion injury and its connection to specific signaling pathways.
  • Induced myocardial ischemia in rats by ligating the coronary artery for 30 min followed by reperfusion for 30 min.
  • Divided 40 rats into four groups: sham, I/R, prophylactic CBD, and therapeutic CBD.
  • Assessed heart and aortic tissues using histopathological, immunohistochemical, biochemical, and genetic analyses to evaluate injury and signaling pathways.
  • The I/R group showed significant myocardial injury indicated by edema and inflammatory infiltration.
  • Prophylactic CBD treatment significantly restored myocardial structure and decreased markers of inflammation and apoptosis.
  • Both prophylactic and therapeutic CBD treatments enhanced mitochondrial biogenesis and reduced oxidative stress compared to the I/R group.

Abstract

Myocardial ischemia-reperfusion (I/R) injury remains a major cause of acute cardiac dysfunction and is characterized by oxidative stress, inflammation, and apoptosis. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, has been reported to exert cardioprotective effects; however, its potential association with mitochondrial biogenesis–related signaling pathways remains incompletely understood. This study aimed to evaluate the cardioprotective potential of CBD in a rat myocardial I/R model and to investigate its possible association with SIRT-1/PGC-1α-related mitochondrial biogenesis and NF-κB-dependent inflammatory signaling. Forty rats were randomly assigned to four groups: sham, I/R, prophylactic CBD, and therapeutic CBD. Myocardial ischemia was induced by ligating the left anterior descending coronary artery for 30 min followed by 30 min of reperfusion. Heart and aortic tissues were evaluated histopathologically, immunohistochemically, biochemically, and genetically to assess oxidative stress, inflammation, and mitochondrial biogenesis-related markers. The I/R group exhibited marked myocardial injury characterized by hyperemia, edema, hemorrhage, and inflammatory infiltration, accompanied by elevated vascular cell adhesion molecule-1 (VCAM-1), vascular endothelial growth factor (VEGF), and NF-κB levels. Conversely, SIRT-1, PGC-1α, and B-cell lymphoma 2 (Bcl-2) expression significantly declined, alongside increased total oxidant status and oxidative stress index. Prophylactic CBD treatment notably restored myocardial architecture, suppressed inflammatory and apoptotic responses, and enhanced mitochondrial biogenesis. Therapeutic CBD administration also provided partial protection. CBD confers robust cardioprotection against myocardial I/R injury by activating the SIRT-1/PGC-1α axis, promoting mitochondrial biogenesis, and attenuating oxidative, inflammatory, and apoptotic pathways. These findings indicated that confers significant cardioprotection against myocardial IR injury and that this protective effect is associated with modulation of SIRT-1/PGC-1α-related mitochondrial biogenesis and NF-κB-dependent inflammatory signaling. Further mechanistic studies are warranted to establish definitive causal relationships.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aksoy et al. (2026) studied this question.

synapsesocial.com/papers/6996a798ecb39a600b3ed660https://doi.org/10.1097/fjc.0000000000001806
Ask AI
Helpful
Bookmark
Share
View Full Paper